Review
Current and Emerging Biomarkers and Surrogate Endpoints in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.